Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (42)

2024

  1. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation

    Virchows Archiv

  2. NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases

    Cancers, Vol. 15, Núm. 6

  2. T regulatory lymphocytes specific for SARS-CoV-2 display increased functional plasticity

    Clinical Immunology, Vol. 256

  3. The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    International journal of molecular sciences, Vol. 24, Núm. 13

2022

  1. Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the in vivo Biological Context

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

    Journal of Personalized Medicine, Vol. 12, Núm. 11

  3. The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors

    American Journal of Surgical Pathology, Vol. 46, Núm. 11, pp. 1545-1553

2020

  1. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161

2019

  1. Intracellular delivery of an antibody targeting gasdermin-b reduces her2 breast cancer aggressiveness

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4846-4858

  2. Molecular basis of tumor heterogeneity in endometrial carcinosarcoma

    Cancers, Vol. 11, Núm. 7

2016

  1. Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 3, pp. E328-E337

  2. The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis

    Oncotarget, Vol. 7, Núm. 48, pp. 78971-78984

2015

  1. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

    Modern Pathology, Vol. 28, Núm. 11, pp. 1492-1503

  2. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

  3. Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT

    International Journal of Cancer, Vol. 136, Núm. 4, pp. E62-E73

2014

  1. A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9

2009

  1. The morphological and molecular features of the epithelial-to-mesenchymal transition

    Nature Protocols, Vol. 4, Núm. 11, pp. 1591-1613

  2. Tiling path genomic profiling of grade 3 invasive ductal breast cancers

    Clinical Cancer Research, Vol. 15, Núm. 8, pp. 2711-2722